— Know what they know.
Not Investment Advice

IPAH OTC

Interpharm Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.8% 1Y: -99.8% 3Y: +0.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $660 mcap · 20M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$74M +18.3% ▲
5Y CAGR: +57.0%
Total Liabilities
$63M +57.2% ▲
5Y CAGR: +87.1%
Shareholders Equity
$11M -50.0% ▼
5Y CAGR: +17.7%
Cash & Investments
$72K -95.0% ▼
5Y CAGR: -44.6%
Total Debt
$27M +69.7% ▲
5Y CAGR: +135.3%
Net Debt
$26M +86.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2002FY2003FY2004FY2005FY2006
— Assets —
Cash$2M$3M$537K$1M$72K
Short-Term Investments$48K$37K$0$0$0
Cash & ST Investments$2M$3M$537K$1M$72K
Net Receivables$6M$7M$8M$14M$13M
Inventory$5M$6M$9M$9M$17M
Other Current Assets$24K$1M$86K$1M$21K
Total Current Assets$13M$17M$18M$27M$32M
Property, Plant & Equip.$4M$15M$22M$29M$34M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$570K$224K$2M$2M$2M
Total Non-Current Assets$7M$18M$28M$36M$42M
Total Assets$20M$35M$46M$63M$74M
— Liabilities —
Accounts Payable$5M$5M$6M$13M$19M
Short-Term Debt$2M$764K$10M$2M$12M
Deferred Revenue$0$0$0$3M$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$8M$5M$17M$18M$31M
Long-Term Debt$238K$7M$7M$14M$14M
Other Non-Current Liab.$30K$0$15K$8M$18M
Total Non-Current Liabilities$267K$7M$7M$22M$32M
Total Liabilities$8M$12M$23M$40M$63M
— Equity —
Common Stock$157K$256K$324K$645K$659K
Retained Earnings$670K$4M$3M-$2M-$19M
Accumulated OCI$12K-$92$0$8K$10K
Total Stockholders Equity$12M$23M$23M$23M$11M
Total Liabilities & Equity$20M$35M$46M$63M$74M
— Key Metrics —
Total Debt$3M$8M$17M$16M$27M
Net Debt$190K$5M$16M$14M$26M
Total Investments$48K$37K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms